Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 13,000
+210 (1.64%)
At close: Jul 31, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 29.99 billion as of July 31, 2026. Its market cap has increased by 13.04% in one year.
Market Cap
29.99B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,000.00
ChartMarket Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 29.99B, a decrease of -48.81%. That is a compound annual growth rate of -19.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 29.99B | -13.33% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TegoScience | 50.28B |
| Parataxis Korea | 44.13B |
| Progen | 42.44B |
| HLB Pep | 37.32B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Quratis | 25.69B |
| Poongjeon Pharmacy CO.,LTD. | 22.99B |